
Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect? Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects
SAN DIEGO–(BUSINESS WIRE)–Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect? (antibody conjugation) and HydraSpac… […]